Analysts’ Weekly Ratings Updates for Danaher (DHR)

Several analysts have recently updated their ratings and price targets for Danaher (NYSE: DHR):

• 1/14/2026 – Danaher was given a new $265.00 price target on by analysts at Argus.
• 1/7/2026 – Danaher had its “buy” rating reaffirmed by analysts at Cowen Inc.
• 1/7/2026 – Danaher had its price target raised by analysts at TD Cowen from $260.00 to $270.00. They now have a “buy” rating on the stock.
• 1/5/2026 – Danaher had its “outperform” rating reaffirmed by analysts at Evercore ISI. They now have a $250.00 price target on the stock.
• 1/2/2026 – Danaher had its price target raised by analysts at Guggenheim from $250.00 to $275.00. They now have a “buy” rating on the stock.
• 12/29/2025 – Danaher had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Danaher had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/18/2025 – Danaher had its “overweight” rating reaffirmed by analysts at KeyCorp.
• 12/17/2025 – Danaher had its price target raised by analysts at Jefferies Financial Group Inc. from $245.00 to $255.00. They now have a “buy” rating on the stock.
• 12/15/2025 – Danaher had its price target raised by analysts at Wells Fargo & Company from $230.00 to $240.00. They now have an “equal weight” rating on the stock.
• 12/9/2025 – Danaher is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $265.00 price target on the stock.
• 12/9/2025 – Danaher is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $265.00 price target on the stock.
• 12/1/2025 – Danaher is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $270.00 price target on the stock.
• 12/1/2025 – Danaher had its price target raised by analysts at HSBC Holdings plc from $255.00 to $270.00. They now have a “buy” rating on the stock.
• 11/22/2025 – Danaher was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. Danaher’s payout ratio is currently 26.39%.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 30,248 shares of company stock valued at $6,609,663 over the last 90 days. Company insiders own 11.10% of the company’s stock.

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.